Fouda, G. G., Cunningham, C. K., McFarland, E. J., Borkowsky, W., Muresan, P., Liebl, B. E., … Permar, S. R. (2013). HIV-1 gp120 Vaccination Elicits a Robust and Durable Anti-V1/V2 IgG Response and Yet No HIV-1 Env-Specific IgA Response in HIV-Exposed Infants. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 29, pp. A13–A14).

Fouda, G. G., C. K. Cunningham, E. J. McFarland, W. Borkowsky, P. Muresan, B. E. Liebl, H. Liao, et al. “HIV-1 gp120 Vaccination Elicits a Robust and Durable Anti-V1/V2 IgG Response and Yet No HIV-1 Env-Specific IgA Response in HIV-Exposed Infants.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 29:A13–14, 2013.

Fouda GG, Cunningham CK, McFarland EJ, Borkowsky W, Muresan P, Liebl BE, et al. HIV-1 gp120 Vaccination Elicits a Robust and Durable Anti-V1/V2 IgG Response and Yet No HIV-1 Env-Specific IgA Response in HIV-Exposed Infants. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013. p. A13–4.

Fouda, G. G., et al. “HIV-1 gp120 Vaccination Elicits a Robust and Durable Anti-V1/V2 IgG Response and Yet No HIV-1 Env-Specific IgA Response in HIV-Exposed Infants.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 29, no. 11, 2013, pp. A13–14.

Fouda GG, Cunningham CK, McFarland EJ, Borkowsky W, Muresan P, Liebl BE, Liao H, Haynes BF, Overman R, Yates NL, Tomaras GD, Permar SR. HIV-1 gp120 Vaccination Elicits a Robust and Durable Anti-V1/V2 IgG Response and Yet No HIV-1 Env-Specific IgA Response in HIV-Exposed Infants. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013. p. A13–A14.